State Street’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172K | Hold |
73,006
| – | – | ﹤0.01% | 3924 |
|
|
2025
Q4 | $174K | Buy |
73,006
+5,700
| +8% | +$14.1K | ﹤0.01% | 3926 |
|
|
2025
Q3 | $179K | Sell |
67,306
-1,220
| -2% | -$3.61K | ﹤0.01% | 3937 |
|
|
2025
Q2 | $204K | Sell |
68,526
-161,169
| -70% | -$469K | ﹤0.01% | 3831 |
|
|
2025
Q1 | $744K | Hold |
229,695
| – | – | ﹤0.01% | 3495 |
|
|
2024
Q4 | $907K | Buy |
229,695
+5,100
| +2% | +$34.8K | ﹤0.01% | 3508 |
|
|
2024
Q3 | $1.74M | Buy |
224,595
+21,752
| +11% | +$143K | ﹤0.01% | 3368 |
|
|
2024
Q2 | $1.04M | Buy |
202,843
+146,317
| +259% | +$1.13M | ﹤0.01% | 3467 |
|
|
2024
Q1 | $460K | Hold |
56,526
| – | – | ﹤0.01% | 3671 |
|
|
2023
Q4 | $226K | Hold |
56,526
| – | – | ﹤0.01% | 3874 |
|
|
2023
Q3 | $233K | Hold |
56,526
| – | – | ﹤0.01% | 3895 |
|
|
2023
Q2 | $336K | Sell |
56,526
-769
| -1% | -$3.47K | ﹤0.01% | 3826 |
|
|
2023
Q1 | $198K | Hold |
57,295
| – | – | ﹤0.01% | 4085 |
|
|
2022
Q4 | $201K | Hold |
57,295
| – | – | ﹤0.01% | 4096 |
|
|
2022
Q3 | $207K | Sell |
57,295
-423
| -0.7% | -$1.99K | ﹤0.01% | 4128 |
|
|
2022
Q2 | $325K | Sell |
57,718
-266,252
| -82% | -$1.79M | ﹤0.01% | 3997 |
|
|
2022
Q1 | $2.8M | Sell |
323,970
-114,887
| -26% | -$1.15M | ﹤0.01% | 3439 |
|
|
2021
Q4 | $4.88M | Buy |
438,857
+3,267
| +0.8% | +$42.5K | ﹤0.01% | 3252 |
|
|
2021
Q3 | $5.64M | Buy |
435,590
+26,836
| +7% | +$428K | ﹤0.01% | 3175 |
|
|
2021
Q2 | $6.77M | Buy |
408,754
+23,414
| +6% | +$397K | ﹤0.01% | 3102 |
|
|
2021
Q1 | $6.62M | Buy |
385,340
+110,430
| +40% | +$2.06M | ﹤0.01% | 2931 |
|
|
2020
Q4 | $4.3M | Buy |
274,910
+2,730
| +1% | +$50.3K | ﹤0.01% | 3037 |
|
|
2020
Q3 | $5.2M | Sell |
272,180
-3,050
| -1% | -$52.6K | ﹤0.01% | 2758 |
|
|
2020
Q2 | $3.77M | Buy |
275,230
+8,761
| +3% | +$123K | ﹤0.01% | 2908 |
|
|
2020
Q1 | $2.83M | Sell |
266,469
-69,010
| -21% | -$1.12M | ﹤0.01% | 2903 |
|
|
2019
Q4 | $6.26M | Sell |
335,479
-16,105
| -5% | -$207K | ﹤0.01% | 2746 |
|
|
2019
Q3 | $3.68M | Buy |
351,584
+76,556
| +28% | +$624K | ﹤0.01% | 2947 |
|
|
2019
Q2 | $2.08M | Buy |
275,028
+252,214
| +1,106% | +$2.19M | ﹤0.01% | 3228 |
|
|
2019
Q1 | $251K | Sell |
22,814
-345
| -1% | -$2.8K | ﹤0.01% | 3545 |
|
|
2018
Q4 | $118K | Sell |
23,159
-398
| -2% | -$1.63K | ﹤0.01% | 3623 |
|
|
2018
Q3 | $75K | Sell |
23,557
-1,855
| -7% | -$7.23K | ﹤0.01% | 3672 |
|
|
2018
Q2 | $114K | Sell |
25,412
-291,314
| -92% | -$1.32M | ﹤0.01% | 3619 |
|
|
2018
Q1 | $1.7M | Buy |
316,726
+8,205
| +3% | +$37.8K | ﹤0.01% | 3223 |
|
|
2017
Q4 | $1.22M | Sell |
308,521
-2,379
| -0.8% | -$10K | ﹤0.01% | 3316 |
|
|
2017
Q3 | $1.36M | Buy |
310,900
+1,153
| +0.4% | +$5.45K | ﹤0.01% | 3313 |
|
|
2017
Q2 | $1.46M | Buy |
309,747
+23,412
| +8% | +$224K | ﹤0.01% | 3245 |
|
|
2017
Q1 | $4.72M | Buy |
286,335
+437
| +0.2% | +$5.72K | ﹤0.01% | 2721 |
|
|
2016
Q4 | $2.89M | Buy |
285,898
+18,352
| +7% | +$244K | ﹤0.01% | 2958 |
|
|
2016
Q3 | $3.6M | Buy |
267,546
+20,668
| +8% | +$303K | ﹤0.01% | 2741 |
|
|
2016
Q2 | $5.16M | Buy |
246,878
+206,318
| +509% | +$2.98M | ﹤0.01% | 2576 |
|
|
2016
Q1 | $383K | Buy |
40,560
+14,290
| +54% | +$118K | ﹤0.01% | 3396 |
|
|
2015
Q4 | $285K | Buy |
26,270
+2,800
| +12% | +$35.8K | ﹤0.01% | 3439 |
|
|
2015
Q3 | $349K | Buy |
23,470
+2,185
| +10% | +$38.2K | ﹤0.01% | 3395 |
|
|
2015
Q2 | $384K | Buy |
+21,285
| New | +$441K | ﹤0.01% | 3402 |
|
Other funds holding XBIT
VCM
RC
BCM
VFT
State Street's XBIT Position: Q1 2026 in Review
State Street held its XBiotech (XBIT) position steady in Q1 2026 at 73,006 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.
State Street first reported a position in XBIT in Q2 2015 and has held it in 44 quarters since. The position peaked at $6.77M in Q2 2021. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.
- State Street held 73,006 shares of XBiotech worth $172K as of Q1 2026.
- State Street left its XBiotech share count unchanged in Q1 2026.
- XBiotech made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3924 holding.
- State Street first reported a position in XBiotech in Q2 2015 and has held it in 44 quarters since.
- State Street's XBiotech position peaked at $6.77M in Q2 2021.
- 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.